retatrutide doses clinical trial Dosage Chart: 2mg to 12mg (Free PDF + Calculator) Retatrutide Dosing: Weekly Injections, Clinical

Only Tirzepatide (GLP-1 + GIP) is available at our clinic

How Your Genetics Relate to GLP-1 Pathways Your baseline lipid panel and metabolic biomarkers provide crucial context for predicting potential GLP-1 treatment effects

GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists These agents are commonly used therapies for managing diabetes and obesity, but gastrointestinal adverse effects such as nausea, vomiting, diarrhea, and constipation frequently limit therapy

Retatrutide is administered as a once-weekly subcutaneous injection, similar in delivery to other peptide-based obesity treatments currently available